Hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting ACTONEL (risedronate sodium) therapy.
Adequate intake of calcium and vitamin D is important in all patients, especially in patients with Paget’s disease in whom bone turnover is significantly elevated (see DRUG